Exciting New Blood Test for Colon Cancer

Show: Health Talk Radio w/ Melanie Cole M.S.

Warning: getimagesize(http://www.healthradio.net/images/stories/web_pics/sharebar.gif) [function.getimagesize]: failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/servers/healthradio.net/www.healthradio.net/modules/mod_valaddthis_15/helper.php on line 113
Dr. Kevin Jones, Ph.D.,
Colon Cancer Screening Breakthrough
Topic Info
"American Cancer Society statistics show that when colon cancer is detected in its early stages, more than 90% of patients will survive. If not detected until the later stages, fewer than 10% will survive. ColoMarker(tm) detects colon cancer in these early, highly curable stages," says Kevin Jones, Ph.D., Chief Scientific Officer of EDP.

According to American Cancer Society statistics, fewer than 20% of Americans over the age of 50 who should be screened for colon cancer, actually are. Dr Jones comes on the show to discuss the use of ColoMarker(tm), a simple and inexpensive blood test, that could potentally increase the number of people being screened and lead to a decline in deaths due to colon cancer.
Guest Info
Dr. Jones is Chief Scientific Officer of EDP Biotech Corporation. Dr. Jones moved into Biotechnoloogy over 18 years ago at BioCell (now known as British Biocell International). After working briefly as a consultant he joined Whatman as Technology Manager Diagnostics in 1997. In 2003 He moved to the US and became Technical Marketing Manager Diagnostics. Kevin joined E$DP Biotech in 2007 as Chief Scientific Officer. In the last 18 years Kevin has authored 12 papers, 34 posters and 6 patents on rapid diagnostics. He is a regular speaker at conferences including those sponsored by the AACC; IFCC; JSCLA; BIVDA and CHI. Kevin has served on committees at BIVDA and the CLSI, and also is a member of the IVD Technology Editorial advisory board. Kevin holds a BSc and PhD in Chemistry from the University of Wales.
Melanie Cole, M.S.
Rate this listing
0 vote



More On-Demand Shows: